Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods

Michael McCulloch, Michael Broffman, Mark van der Laan, Alan Hubbard, Lawrence Kushi, Donald I Abrams, Jin Gao, John M Colford Jr, Michael McCulloch, Michael Broffman, Mark van der Laan, Alan Hubbard, Lawrence Kushi, Donald I Abrams, Jin Gao, John M Colford Jr

Abstract

Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95%, stage II by 64%, stage III by 29%, and stage IV by 75%. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.

Figures

Figure 1. Survival in colon cancer, short-term…
Figure 1. Survival in colon cancer, short-term versus long-term PAM+V and external controls
Abbreviations: PAM+V, Pan-Asian medicine + vitamins; PS, Pine Street Clinic; KPNC, Kaiser Permanente Northern California; CCR, California Cancer Registry.
Figure 2
Figure 2
Colon cancer survival, showing all treatment combinations of PAM+V and surgery, using California Cancer Registry patients as external controls Abbreviation: PAM+V, Pan-Asian medicine plus vitamins.
Figure 3
Figure 3
Colon cancer survival, showing all treatment combinations of PAM+V and chemotherapy, using California Cancer Registry patients as external controls Abbreviation: PAM+V, Pan-Asian medicine plus vitamins.
Figure 4
Figure 4
Colon cancer survival, showing all treatment combinations of PAM+V and radiotherapy, using California Cancer Registry patients as external controls Abbreviation: PAM+V, Pan-Asian medicine plus vitamins.
Figure 5
Figure 5
Colon cancer survival, showing all treatment combinations of PAM+V and any conventional therapy, using California Cancer Registry patients as external controls Abbreviation: PAM+V, Pan-Asian medicine plus vitamins.
Figure 6
Figure 6
Colon cancer survival, comparing PAM+V patients initially treated at PS with those followed up at other CAM centers Abbreviation: PAM+V, Pan-Asian medicine plus vitamins; PS, Pine Street Clinic; CAM, complementary and alternative medicine.
Figure 7
Figure 7
Colon cancer survival, comparing patients treated with long-term and short-term PAM+V with CAM users and nonusers from within the California Cancer Registry database Abbreviation: PAM+V, Pan-Asian medicine plus vitamins; CAM, complementary and alternative medicine.

Source: PubMed

3
Sottoscrivi